Ultragenyx Pharmaceutical Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Return On Equity for the quarter ending September 30, 2024 was -187 %, a 46% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2023 was -370 %, a 200% decline from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2022 was -123 %, a 164% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2021 was -46.8 %, a 95.9% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -187 +159 +46% Jul 1, 2024 Sep 30, 2024
Q2 2024 -266 -19.8 -8.04% Apr 1, 2024 Jun 30, 2024
Q1 2024 -426 -258 -155% Jan 1, 2024 Mar 31, 2024
Q4 2023 -370 -246 -200% Oct 1, 2023 Dec 31, 2023
Q3 2023 -346 -252 -266% Jul 1, 2023 Sep 30, 2023
Q2 2023 -246 -185 -305% Apr 1, 2023 Jun 30, 2023
Q1 2023 -167 -115 -222% Jan 1, 2023 Mar 31, 2023
Q4 2022 -123 -76.5 -164% Oct 1, 2022 Dec 31, 2022
Q3 2022 -94.6 -60.1 -174% Jul 1, 2022 Sep 30, 2022
Q2 2022 -60.8 -24.2 -66.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -51.9 -29.1 -127% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.8 -22.9 -95.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -34.6 +4.5 +11.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.5 +8.22 +18.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.8 +37.7 +62.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -23.9 +28.3 +54.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -39.1 +13.1 +25.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -44.8 +5.08 +10.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.5 -15.1 -33.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -52.2 -22.9 -78.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -52.2 -21.2 -68.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -49.8 -16.1 -47.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -45.4 -2.55 -5.96% Jan 1, 2019 Mar 31, 2019
Q4 2018 -29.3 +43.2 +59.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -31 +35.4 +53.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -33.7 +26.3 +43.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -42.8 +13.3 +23.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -72.5 -19.7 -37.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -66.4 -18.5 -38.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -60 -20.1 -50.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -56.2 -19.2 -52% Jan 1, 2017 Mar 31, 2017
Q4 2016 -52.8 -19.8 -60.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -47.9 -17.7 -58.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -40 -7.93 -24.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -36.9 -6.17 -20.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -32.9 +1.08 +3.17% Oct 1, 2015 Dec 31, 2015
Q3 2015 -30.1 +18.9 +38.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -32.1 Apr 1, 2015 Jun 30, 2015
Q1 2015 -30.8 Jan 1, 2015 Mar 31, 2015
Q4 2014 -34 Oct 1, 2014 Dec 31, 2014
Q3 2014 -49.1 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.